Calysta, Inc. is a biotechnology company specializing in the development and manufacture of protein ingredients derived from innovative sources. Founded in 2011 and headquartered in Menlo Park, California, with additional facilities in Houston, London, Stavanger, and Singapore, Calysta focuses on producing nutritional feeds and health products for fish and livestock. The company utilizes a patented fermentation platform that operates without arable land, plant, or animal products, thereby promoting sustainability in food production. Its product line includes FeedKind, FeedKind Net Zero, and Positive Protein, which aim to address the increasing global demand for sustainably produced food while preserving biodiversity. Additionally, Calysta produces industrial chemicals and biofuels from methane, contributing to enhanced food security and the efficient use of resources. The company has established a strategic partnership with Bluestar Adisseo Company to further its mission in the field of cellular agriculture.
Calysta, Inc. is a biotechnology company specializing in the development and manufacture of protein ingredients derived from innovative sources. Founded in 2011 and headquartered in Menlo Park, California, with additional facilities in Houston, London, Stavanger, and Singapore, Calysta focuses on producing nutritional feeds and health products for fish and livestock. The company utilizes a patented fermentation platform that operates without arable land, plant, or animal products, thereby promoting sustainability in food production. Its product line includes FeedKind, FeedKind Net Zero, and Positive Protein, which aim to address the increasing global demand for sustainably produced food while preserving biodiversity. Additionally, Calysta produces industrial chemicals and biofuels from methane, contributing to enhanced food security and the efficient use of resources. The company has established a strategic partnership with Bluestar Adisseo Company to further its mission in the field of cellular agriculture.
Trice Medical
Series C in 2019
Trice Medical, Inc. is a company that specializes in the development of innovative orthopedic diagnostic devices featuring integrated camera-enabled and needle-based technologies. Founded in 2011 and headquartered in Malvern, Pennsylvania, Trice Medical aims to enhance patient care by providing immediate and accurate diagnostic solutions that can be administered in a physician's office. Their products facilitate minimally invasive procedures that are designed to be painless, cosmetically undetectable, and of surgical grade quality. By optimizing the diagnostic process, Trice Medical seeks to eliminate inaccuracies associated with traditional indirect modalities, thereby reducing costs for the healthcare system while improving the overall patient experience.
Calysta, Inc. is a biotechnology company specializing in the development and manufacture of protein ingredients derived from innovative sources. Founded in 2011 and headquartered in Menlo Park, California, with additional facilities in Houston, London, Stavanger, and Singapore, Calysta focuses on producing nutritional feeds and health products for fish and livestock. The company utilizes a patented fermentation platform that operates without arable land, plant, or animal products, thereby promoting sustainability in food production. Its product line includes FeedKind, FeedKind Net Zero, and Positive Protein, which aim to address the increasing global demand for sustainably produced food while preserving biodiversity. Additionally, Calysta produces industrial chemicals and biofuels from methane, contributing to enhanced food security and the efficient use of resources. The company has established a strategic partnership with Bluestar Adisseo Company to further its mission in the field of cellular agriculture.
Aperia Technologies
Series B in 2016
Aperia Technologies, Inc. is a company that specializes in automatic tire inflation devices aimed at enhancing the safety and efficiency of commercial vehicles. Its flagship product, the Halo Tire Inflator, is a self-powered, bolt-on device that utilizes the rotational motion of a wheel to maintain optimal tire pressure by compensating for minor leaks and pressure changes due to temperature fluctuations. This technology is particularly beneficial for a variety of fleet vehicles, including buses, box trucks, tractors, trailers, and refuse vehicles. By ensuring proper tire inflation, Aperia Technologies helps fleet operators reduce fuel costs, decrease environmental pollution, and improve overall road safety. Founded in 2010, the company is headquartered in Burlingame, California, and distributes its products through a network of dealers across the United States.
Calysta, Inc. is a biotechnology company specializing in the development and manufacture of protein ingredients derived from innovative sources. Founded in 2011 and headquartered in Menlo Park, California, with additional facilities in Houston, London, Stavanger, and Singapore, Calysta focuses on producing nutritional feeds and health products for fish and livestock. The company utilizes a patented fermentation platform that operates without arable land, plant, or animal products, thereby promoting sustainability in food production. Its product line includes FeedKind, FeedKind Net Zero, and Positive Protein, which aim to address the increasing global demand for sustainably produced food while preserving biodiversity. Additionally, Calysta produces industrial chemicals and biofuels from methane, contributing to enhanced food security and the efficient use of resources. The company has established a strategic partnership with Bluestar Adisseo Company to further its mission in the field of cellular agriculture.